Elan, Biogen Change Terms Of Tysabri Collaboration

Biogen Idec will take over full ownership of the multiple sclerosis treatment Tysabri from its partner Irish drugmaker Elan Corp. PLC in exchange for a $3.25 billion cash payment and royalties…

Topics:  biogen idec   tysabri   irish   elan   corp   change   
BING NEWS:
  • StockWatch: Biogen Q1 Results Beat Expectations, for a Change
    Investors and analysts are so used to bad news from Biogen (BIIB) that they seemingly didn’t know how to react when the biotech giant delivered better first quarter results than expected.
    04/27/2024 - 12:41 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News